BioCentury
ARTICLE | Company News

Reed leaving Roche's pRED division

March 8, 2018 6:52 PM UTC

Roche (SIX:ROG; OTCQX:RHHBY) said John Reed, the head of its Pharma Research and Early Development unit, is leaving the company for "personal reasons" and returning to the U.S., effective April 2. William Pao, global head of the oncology discovery and translational area for pRED, will succeed Reed and will be based in Basel, Switzerland...

BCIQ Company Profiles

Roche